Stockreport

Rallybio to Initiate RLYB116 Confirmatory Clinical PK/PD Study in Second Quarter 2025 [Yahoo! Finance]

Rallybio Corporation  (RLYB) 
PDF -- Manufacturing Process Enhancements Expected to Further Improve RLYB116 Tolerability -- -- Webcast Today at 8:30 AM Eastern Time -- NEW HAVEN, Conn., December 02, [Read more]